Press Releases

GREENVILLE, N.C.--(BUSINESS WIRE)-- First responders, faced with ever-increasing dangers during everyday job duties, have new resources from the Armor NOW (www.armornow.com) ed

ST. LOUIS--(BUSINESS WIRE)-- Advantage Capital today announced a $7.55 million investment in Mirac, Inc., a rural Ohio-based electronics assembly and fabrication company with locations in Lynchburg and West Union, that will help keep jobs in rural Ohio. Since its founding in 1992, Mirac has been a significant part of the Lynchburg community. The largest employer in the region, Mirac added a se

SAN FRANCISCO--(BUSINESS WIRE)-- Doctor On Demand, the nation’s leading virtual care provider, today announced the expansion of its leadership team with a number of

RALEIGH, N.C.--(BUSINESS WIRE)-- Merz, a global leader in medical aesthetics, presented five-year follow-up data on Cellfina® System, which showed that a single treatment improved the appearance of cellulite on the thighs and buttocks for five years, building upon a previous study, which showed results lasting at least three years—the longest FDA clearance for a cellulite treatment. The piv

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- BP p.l.c. (NYSE: BP) and

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Zingbox, the provider of the most widely deployed healthcare Internet of Things (IoT) analytics platform, today announced that Bear Valley Co

CINCINNATI--(BUSINESS WIRE)-- P&G-owned hair care brand Herbal Essences is producing the first-ever mass hair care bottle design in North America that will make it easier for vision impaired consumers to distinguish its shampoo and conditioner products through the sense of touch. The newly enhanced package features tactile indentations that will help differentiate the brand’s shampoos from its conditi

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Imara Inc. today announced it will provide an update on its sickle cell disease program at the Sickle Cell Disease Association of America’s (SCDAA) 46th Annual National Convention. Dr. Carolyn Hoppe of UCSF Benioff Children’s Hospital Oakland Research Institute (CHORI), and a principal investigator of Imara’s Phase 2 clinical trial of IMR-687, wil

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Synspira, a privately held company developing a new class of inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease,

BRISBANE, Australia & CARLSBAD, Calif.--(BUSINESS WIRE)-- In recognition of October as Breast Cancer Awareness Month, ImpediMed Limited (ASX:IPD), a global provider of medi

NEW YORK--(BUSINESS WIRE)-- Coord, the mobility data platform, today announced the closing of a $5 million Series A investment. The investment was led by Alliance Ventures, with additional funds coming from Trucks, Urban.Us and DB Digital Ventures. They join previous investor Sidewalk Labs, an Alphabet company. While continuing to reach developers with their robust suite of self-serve APIs, Co

WASHINGTON--(BUSINESS WIRE)-- Buchanan & Edwards Inc., an award-winning and fast-growing technology leader creating transformative solutions for government

CHICAGO--(BUSINESS WIRE)-- Motorola Solutions (NYSE: MSI) today announced an exclusive partnership with the government division of LexisNexis® Risk Solutions, a leading global provider of information and analytics. The partnership will bring LexisNexis Risk Solutions data and analytics into Motorola Solutions’ public safety software platform, enabling users to better focus investigations, detect patte

NEW HAVEN, Conn.--(BUSINESS WIRE)-- The cognitive science company, Cogstate Ltd (ASX:CGS) today announced a presentation entitled, “Methodology for Development of Indication-Specific Outcome Measures in Rare Disease Trials: An Innovative Research Approach” will be delivered at the National Organization for Rare Diseases (NORD) Rare Disease Summit in Washington, D.C. The poster will be presented on O

GRAND RAPIDS, Mich.--(BUSINESS WIRE)-- Tetra Discovery Partners today announced that the U.S. Patent and Trademark Office has issued a third patent covering the company’s selective phosphodiesterase-4D (PDE4D) inhibitor, BPN 14770, and related compounds. The new patent, US 10,093,686, covers claims for the use such compounds in the treatment of mild cognitive impairment, Parkinson’s disease, stroke